Showing 1 - 7 results of 7 for search 'John M Dennis', query time: 0.03s
Refine Results
-
1
Acceleration of the Parameterization of Unified Microphysics Across Scales (PUMAS) on the Graphics Processing Unit (GPU) With Directive‐Based Methods by Jian Sun, John M. Dennis, Sheri A. Mickelson, Brian Vanderwende, Andrew Gettelman, Katherine Thayer‐Calder
Published 2023-05-01
Article -
2
Dirichlet process mixture models to impute missing predictor data in counterfactual prediction models: an application to predict optimal type 2 diabetes therapy by Pedro Cardoso, John M. Dennis, Jack Bowden, Beverley M. Shields, Trevelyan J. McKinley, the MASTERMIND Consortium
Published 2024-01-01
Article -
3
Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: an application for type 2 diabetes precision medicine by Ashwini Venkatasubramaniam, Bilal A. Mateen, Beverley M. Shields, Andrew T. Hattersley, Angus G. Jones, Sebastian J. Vollmer, John M. Dennis
Published 2023-06-01
Article -
4
Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy by Katherine G. Young, Rhian Hopkins, Beverley M. Shields, Nicholas J. Thomas, Andrew P. McGovern, John M. Dennis, the MASTERMIND consortium
Published 2023-11-01
Article -
5
Hospital bed capacity and usage across secondary healthcare providers in England during the first wave of the COVID-19 pandemic: a descriptive analysis by Sebastian Vollmer, John M Dennis, Spiros Denaxas, Andrew McGovern, Nick Thomas, Bilal Akhter Mateen, Harrison Wilde, Andrew Duncan, Matt Keeling
Published 2021-01-01
Article -
6
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study by Beverley M Shields, Bilal A Mateen, Andrew P McGovern, John M Dennis, Sebastian J Vollmer, Daniyal Raja, Rhian Hopkins, Katherine G Young, Nicholas J Thomas, James Godwin, Robert J Challen
Published 2024-01-01
Article -
7
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review by Katherine G. Young, Eram Haider McInnes, Robert J. Massey, Anna R. Kahkoska, Scott J. Pilla, Sridharan Raghavan, Maggie A. Stanislawski, Deirdre K. Tobias, Andrew P. McGovern, Adem Y. Dawed, Angus G. Jones, Ewan R. Pearson, John M. Dennis, ADA/EASD PDMI
Published 2023-10-01
Article